Epigenetic regulation of inflammation by microRNAs in post-infectious bronchiolitis obliterans

IF 4.6 2区 医学 Q2 IMMUNOLOGY
Ruth P Duecker, Ines De Mir Messa, Silvija-Pera Jerkic, Annalena Kochems, Gabriele Gottwald, Antonio Moreno-Galdó, Martin Rosewich, Lucia Gronau, Stefan Zielen, Andreas Geburtig-Chiocchetti, Hermann Kreyenberg, Ralf Schubert
{"title":"Epigenetic regulation of inflammation by microRNAs in post-infectious bronchiolitis obliterans","authors":"Ruth P Duecker,&nbsp;Ines De Mir Messa,&nbsp;Silvija-Pera Jerkic,&nbsp;Annalena Kochems,&nbsp;Gabriele Gottwald,&nbsp;Antonio Moreno-Galdó,&nbsp;Martin Rosewich,&nbsp;Lucia Gronau,&nbsp;Stefan Zielen,&nbsp;Andreas Geburtig-Chiocchetti,&nbsp;Hermann Kreyenberg,&nbsp;Ralf Schubert","doi":"10.1002/cti2.1376","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>Post-infectious bronchiolitis obliterans (PiBO) is a rare, chronic disease initiated by severe infection and followed by perpetuating inflammation and obliteration of the small airways. MicroRNAs (miRNAs) have been proposed to play a central role as epigenetic regulators, which control resolution and prevent the uncontrolled progress of inflammation. The aim of this study was to define biomarkers on the level of post-transcriptional gene regulation in order to characterise PiBO.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A total of 39 patients with well-defined PiBO and 31 controls from two centres, Barcelona, Spain, and Frankfurt, Germany, were analysed by next-generation sequencing (NGS). The evaluation of the biological targets of the miRNAs was performed by pathway enrichment analysis and protein–protein interaction network analysis respectively.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Patients with PiBO had significantly lower lung function values and increased airway inflammation in induced sputum as indicated by total cell counts, neutrophils, IL-1β, IL-6, IL-8 and TGF-β compared to controls.</p>\n \n <p>Next-generation sequencing analysis revealed a total of 22 dysregulated miRNAs, which passed significance threshold for <i>P</i>adj ≤ 0.001 with 17 being upregulated and 5 being downregulated. Of these dysregulated miRNAs, miR-335-5p, miR-186-5p, miR-30b-5p and miR-30c-5p were further validated using qRT-PCR. Interestingly, these miRNAs are functionally implicated in cytokine–cytokine receptor interaction, TGF-β signalling and FoxO signalling pathway and significantly correlated with lung function values (FEV1).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our results demonstrate an aberrant miRNA expression profile in PiBO, which impacts pathways responsible for the regulation of inflammation and fibrosis. The defined miRNAs are useful biomarkers and should be assessed as potential target in the field of miRNA therapeutics.</p>\n </section>\n </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"11 2","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2022-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.1376","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cti2.1376","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Objectives

Post-infectious bronchiolitis obliterans (PiBO) is a rare, chronic disease initiated by severe infection and followed by perpetuating inflammation and obliteration of the small airways. MicroRNAs (miRNAs) have been proposed to play a central role as epigenetic regulators, which control resolution and prevent the uncontrolled progress of inflammation. The aim of this study was to define biomarkers on the level of post-transcriptional gene regulation in order to characterise PiBO.

Methods

A total of 39 patients with well-defined PiBO and 31 controls from two centres, Barcelona, Spain, and Frankfurt, Germany, were analysed by next-generation sequencing (NGS). The evaluation of the biological targets of the miRNAs was performed by pathway enrichment analysis and protein–protein interaction network analysis respectively.

Results

Patients with PiBO had significantly lower lung function values and increased airway inflammation in induced sputum as indicated by total cell counts, neutrophils, IL-1β, IL-6, IL-8 and TGF-β compared to controls.

Next-generation sequencing analysis revealed a total of 22 dysregulated miRNAs, which passed significance threshold for Padj ≤ 0.001 with 17 being upregulated and 5 being downregulated. Of these dysregulated miRNAs, miR-335-5p, miR-186-5p, miR-30b-5p and miR-30c-5p were further validated using qRT-PCR. Interestingly, these miRNAs are functionally implicated in cytokine–cytokine receptor interaction, TGF-β signalling and FoxO signalling pathway and significantly correlated with lung function values (FEV1).

Conclusion

Our results demonstrate an aberrant miRNA expression profile in PiBO, which impacts pathways responsible for the regulation of inflammation and fibrosis. The defined miRNAs are useful biomarkers and should be assessed as potential target in the field of miRNA therapeutics.

感染后闭塞性细支气管炎的microrna炎症的表观遗传调控
目的:传染性后闭塞性毛细支气管炎(PiBO)是一种罕见的慢性疾病,由严重感染引发,随后持续炎症和小气道闭塞。MicroRNAs (miRNAs)被认为在表观遗传调控中发挥核心作用,控制炎症的消退并防止炎症的不受控制的进展。本研究的目的是在转录后基因调控水平上定义生物标志物,以表征PiBO。方法采用新一代测序(NGS)技术对来自西班牙巴塞罗那和德国法兰克福两个中心的39例明确定义的PiBO患者和31例对照组进行分析。分别通过途径富集分析和蛋白-蛋白相互作用网络分析对mirna的生物学靶点进行评价。结果与对照组相比,PiBO患者的肺功能值明显降低,诱导痰中气道炎症反应明显增加,包括总细胞计数、中性粒细胞、IL-1β、IL-6、IL-8和TGF-β。新一代测序分析显示,共有22个mirna表达异常,通过显著性阈值(Padj≤0.001),其中17个表达上调,5个表达下调。在这些失调的mirna中,miR-335-5p、miR-186-5p、miR-30b-5p和miR-30c-5p通过qRT-PCR进一步验证。有趣的是,这些mirna在功能上涉及细胞因子-细胞因子受体相互作用、TGF-β信号传导和FoxO信号传导途径,并与肺功能值显著相关(FEV1)。结论:我们的研究结果表明,PiBO中存在异常的miRNA表达谱,其影响了炎症和纤维化的调节途径。已定义的miRNA是有用的生物标志物,应作为miRNA治疗领域的潜在靶点进行评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical & Translational Immunology
Clinical & Translational Immunology Medicine-Immunology and Allergy
CiteScore
12.00
自引率
1.70%
发文量
77
审稿时长
13 weeks
期刊介绍: Clinical & Translational Immunology is an open access, fully peer-reviewed journal devoted to publishing cutting-edge advances in biomedical research for scientists and physicians. The Journal covers fields including cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信